GFAP and early-onset autosomal dominant Alzheimer disease: Furthermore, our ADAD data and the longitudinal association between glucose metabolism and plasma GFAP changes suggest that plasma GFAP changes could be a later marker in the Alzheimer’s disease trajectory than earlier thought and could even reflect an Alzheimer’s disease-related degeneration of astrocytes.